For: | Stahl M, Kim TK, Zeidan AM. Update on acute myeloid leukemia stem cells: New discoveries and therapeutic opportunities. World J Stem Cells 2016; 8(10): 316-331 [PMID: 27822339 DOI: 10.4252/wjsc.v8.i10.316] |
---|---|
URL: | https://www.wjgnet.com/1948-0210/full/v8/i10/316.htm |
Number | Citing Articles |
1 |
Mahdi Pakjoo, Seyed Esmaeil Ahmadi, Mohammad Zahedi, Niloofar Jaafari, Reyhane Khademi, Ali Amini, Majid Safa. Interplay between proteasome inhibitors and NF-κB pathway in leukemia and lymphoma: a comprehensive review on challenges ahead of proteasome inhibitors. Cell Communication and Signaling 2024; 22(1) doi: 10.1186/s12964-023-01433-5
|
2 |
Chi H. Nguyen, Alexander M. Grandits, Louise E. Purton, Heinz Sill, Rotraud Wieser. All-trans retinoic acid in non-promyelocytic acute myeloid leukemia: driver lesion dependent effects on leukemic stem cells. Cell Cycle 2020; 19(20): 2573 doi: 10.1080/15384101.2020.1810402
|
3 |
Ziqi Feng, Zelin Wang, Yun Yang, Yuzhi Du, Sixin Cui, Yi Zhang, Yanan Tong, Zhen Song, Hao Zeng, Quanming Zou, Liusheng Peng, Hongwu Sun. Development of a safety and efficacy nanoemulsion delivery system encapsulated gambogic acid for acute myeloid leukemia in vitro and in vivo. European Journal of Pharmaceutical Sciences 2018; 125: 172 doi: 10.1016/j.ejps.2018.10.001
|
4 |
Luyun Peng, Yuanting Tang, Yingchi Zhang, Siqi Guo, Leiwen Peng, Lei Ye, Yuefang Wang, Yongmei Jiang. Structural maintenance of chromosomes 4 is required for leukemia stem cell maintenance in MLL-AF9 induced acute myeloid leukemia. Leukemia & Lymphoma 2018; 59(10): 2423 doi: 10.1080/10428194.2017.1387906
|
5 |
Chi Huu Nguyen, Alexander M. Grandits, George S. Vassiliou, Philipp B. Staber, Gerwin Heller, Rotraud Wieser. Evi1 Counteracts Anti-Leukemic and Stem Cell Inhibitory Effects of All-Trans Retinoic Acid on Flt3-ITD/Npm1c-Driven Acute Myeloid Leukemia Cells. Biomedicines 2020; 8(10): 385 doi: 10.3390/biomedicines8100385
|
6 |
Alexander M. Grandits, Rotraud Wieser. Gene expression changes contribute to stemness and therapy resistance of relapsed acute myeloid leukemia: roles of SOCS2, CALCRL, MTSS1, and KDM6A. Experimental Hematology 2021; 99: 1 doi: 10.1016/j.exphem.2021.05.004
|
7 |
Matthew Masoudi, Vinod Gopalan. Cancer Stem Cells: Basic Concept and Therapeutic Implications. 2023; : 149 doi: 10.1007/978-981-99-3185-9_9
|
8 |
Jan Philipp Bewersdorf, Maximilian Stahl, Amer M. Zeidan. Are we witnessing the start of a therapeutic revolution in acute myeloid leukemia?. Leukemia & Lymphoma 2019; 60(6): 1354 doi: 10.1080/10428194.2018.1546854
|
9 |
Jan Philipp Bewersdorf, Rory M. Shallis, Rong Wang, Scott F. Huntington, Sarah Perreault, Xiaomei Ma, Amer M. Zeidan. Healthcare expenses for treatment of acute myeloid leukemia. Expert Review of Hematology 2019; 12(8): 641 doi: 10.1080/17474086.2019.1627869
|
10 |
Lindsay Wilde, Sabarina Ramanathan, Margaret Kasner. B-cell lymphoma-2 inhibition and resistance in acute myeloid leukemia. World Journal of Clinical Oncology 2020; 11(8): 528-540 doi: 10.5306/wjco.v11.i8.528
|
11 |
Maximilian Stahl, Benjamin Y. Lu, Tae Kon Kim, Amer M. Zeidan. Novel Therapies for Acute Myeloid Leukemia: Are We Finally Breaking the Deadlock?. Targeted Oncology 2017; 12(4): 413 doi: 10.1007/s11523-017-0503-8
|
12 |
Maria De Grandis, Florence Bardin, Cyril Fauriat, Christophe Zemmour, Abdessamad El-Kaoutari, Arnauld Sergé, Samuel Granjeaud, Laurent Pouyet, Camille Montersino, Anne-Sophie Chretien, Marie-Joelle Mozziconacci, Remy Castellano, Ghislain Bidaut, Jean-Marie Boher, Yves Collette, Stéphane J.C. Mancini, Norbert Vey, Michel Aurrand-Lions. JAM-C Identifies Src Family Kinase-Activated Leukemia-Initiating Cells and Predicts Poor Prognosis in Acute Myeloid Leukemia. Cancer Research 2017; 77(23): 6627 doi: 10.1158/0008-5472.CAN-17-1223
|
13 |
Cristina Mambet, Mihaela Chivu-Economescu, Lilia Matei, Laura Georgiana Necula, Denisa Laura Dragu, Coralia Bleotu, Carmen Cristina Diaconu. Murine models based on acute myeloid leukemia-initiating stem cells xenografting. World Journal of Stem Cells 2018; 10(6): 57-65 doi: 10.4252/wjsc.v10.i6.57
|
14 |
Ran Li, Xiaolu Wu, Kai Xue, Junmin Li. ITGAL infers adverse prognosis and correlates with immunity in acute myeloid leukemia. Cancer Cell International 2022; 22(1) doi: 10.1186/s12935-022-02684-x
|
15 |
Mingxue Fan, Minghao Li, Lipeng Gao, Sicong Geng, Jing Wang, Yiting Wang, Zhiqiang Yan, Lei Yu. Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia. Journal of Hematology & Oncology 2017; 10(1) doi: 10.1186/s13045-017-0519-7
|